QHSLab, Inc. (USAQ): Gross Profit

Annual figures by period end, from SEC filings.

$1.81M
Year ended 2025-12-31
$2.04M
Trailing 12 months to 2026-06-30
+43.0%
3-year compound annual growth
+104.9%
5-year compound annual growth
2020-12-31: $50.1K2021-12-31: $670.7K2022-12-31: $619.5K2023-12-31: $793.6K2024-12-31: $1.36M2025-12-31: $1.81M$1.81M
2020-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$1.81M+33.4%2026-03-30, From 2025-01-01
2024-12-31$1.36M+71.1%2026-03-30, From 2024-01-01
2023-12-31$793.6K+28.1%2025-03-28, From 2023-01-01
2022-12-31$619.5K-7.6%2024-03-27, From 2022-01-01
2021-12-31$670.7Kn/m2023-03-29, From 2021-01-01
2020-12-31$50.1Kn/a2022-04-01, From 2020-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
QHSLab, Inc. (USAQ)2025-12-31$1.81M+33.4%
OSR Health, Inc. (OSRH)2025-12-31$592.9K-26.9%
Femasys Inc (FEMY)2025-12-31$1.42M+31.1%
Nuo Therapeutics, Inc. (AURX)2025-12-31$2.22M+108.8%
IceCure Medical Ltd. (ICCM)2025-12-31$1.23M-15.5%
Vycor Medical Inc (VYCO)2025-12-31$1.56M+9.7%
Tenon Medical, Inc. (TNON)2025-12-31$2.36M+37.8%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.05M+64.4%
EBR Systems, Inc. (NONE.)2025-12-31$490.0Kn/a

Compare USAQ, OSRH, FEMY, AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗